Synergistic immunotherapy of glioblastoma by dual targeting of IL-6 and CD40
Cited by 151
Related Papers
Vascular niche IL-6 induces alternative macrophage activation in glioblastoma through HIF-2α
|Nature Communications|2018|290
PDGF-mediated mesenchymal transformation renders endothelial resistance to anti-VEGF treatment in glioblastoma
|Nature Communications|2018|153
c-Met–mediated endothelial plasticity drives aberrant vascularization and chemoresistance in glioblastoma
|Journal of Clinical Investigation|2016|123
Small-molecule toosendanin reverses macrophage-mediated immunosuppression to overcome glioblastoma resistance to immunotherapy
|Science Translational Medicine|2023|60